Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 139Breast Neoplasms 31Prostatic Neoplasms 29Insulin Resistance 28Obesity 19Pancreatic Neoplasms 13Neoplasms 12Infertility 12Endometrial Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Colorectal Neoplasms 11Anovulation 9Lung Neoplasms 8Metabolic Syndrome 7Melanoma 7Hyperandrogenism 7Glioblastoma 7Diabetes Mellitus 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Rectal Neoplasms 5Adenocarcinoma 5Weight Loss 4Urinary Bladder Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Carcinoma, Ovarian Epithelial 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Recurrence 3

Interventions

Exercise 5Vitamin D 3Resistance Training 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Oxycodone 2Omeprazole 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Dexmedetomidine 2Blood Specimen Collection 2Aspirin 2ziprasidone 1soybean oil, phospholipid emulsion 1semaglutide 1montelukast 1microcrystalline cellulose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Inflammation × Metformin × Clear all
NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed
50 enrolled

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

NCT02689843 2019-11-12

AntiPCO

Shiraz University of Medical Sciences

Phase EARLY_PHASE1 Completed
90 enrolled

Inflammation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡